Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000882162 | SCV001025387 | likely benign | Tuberous sclerosis 1 | 2024-01-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001018933 | SCV001180230 | likely benign | Hereditary cancer-predisposing syndrome | 2018-02-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genome- |
RCV000882162 | SCV002040481 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002501392 | SCV002801742 | likely benign | Lymphangiomyomatosis; Tuberous sclerosis 1; Isolated focal cortical dysplasia type II | 2021-12-15 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004003136 | SCV004840510 | likely benign | Tuberous sclerosis syndrome | 2023-08-15 | criteria provided, single submitter | clinical testing |